- Preparation method of loxoprofen
-
The invention discloses a novel preparation method of loxoprofen (I). The reaction process comprises the following steps: a compound (VII) and a compound (VIII) are subjected to a condensation reaction to obtain an intermediate (IX), the intermediate (IX) is subjected to a hydrogenation reduction reaction in a mixed solvent of acid and alcohol to obtain an intermediate (X), and the intermediate (X) is subjected to a hydrolysis reaction to obtain loxoprofen (I).
- -
-
Paragraph 0038; 0044-0045
(2020/07/27)
-
- Ni-catalyzed direct alcoholysis of N-acylpyrrole-type tertiary amides under mild conditions
-
N-Acylpyrrole-type amides are a class of versatile building blocks in asymmetric synthesis. We report that by employing Ni(COD)2/2,2′-bipyridine (5 mol%) catalytic system, the direct, catalytic alcoholysis of N-acylpyrrole-type aromatic and aliphatic amides with both primary and secondary alcohols can be achieved efficiently under very mild conditions (rt, 1 h) even at gram scale. By increasing the catalyst loading to 10 mol%, prolonging reaction time (18 h), and/or elevating reaction temperature to 50 °C/80 °C, the reaction could be extended to both complex and hindered N-acylpyrroles as well as to N-acylpyrazoles, Nacylindoles, and to other (functionalized) primary and secondary alcohols. In all cases, only 1.5 equiv. of alcohol were used. The value of the method has been demonstrated by the racemization-free, catalytic alcoholysis of chiral amides yielded from other asymmetric methodologies.
- Chen, Hang,Chen, Dong-Huang,Huang, Pei-Qiang
-
p. 370 - 376
(2020/03/03)
-
- A substituted phenylacetic acid derivatives (by machine translation)
-
The invention belongs to the field of drug synthesis, relates to a substituted phenylacetic acid derivatives, in particular to the preparation of 2 - [4 - (2 - methyl oxygen fifth heavenly stem) hydrocinnamic acid] preparation method. If nitrile alkylation reaction include alkylation reaction, reaction or ester alkyl [...] reaction to prepare the intermediate type II - 2 or type II - 2' compound, After the hydrolytic reaction or oxidation reaction preparation to obtain the product. The invention relates to the alkylation reaction without additional solvent, is a more industrialization of the advantages of the line. (by machine translation)
- -
-
Paragraph 0045; 0046
(2019/04/18)
-
- Method for preparing loxoprofen sodium
-
The invention relates to the technical field of organic synthesis, in particular to a method for preparing loxoprofen sodium. The invention provides a compound with the structure shown in formula 5 and a preparation method and application of the compound, (the formula is defined in the description). The loxoprofen sodium obtained according to the scheme is high in purity, high in industrialized operation, and good in application prospect.
- -
-
Paragraph 0112-0114
(2017/07/12)
-
- GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME
-
The present invention provides a glycosaminoglycan derivative in which a group derived from glycosaminoglycan and a group derived from a physiologically active substance having at least one of a carboxy group and a hydroxy group are coupled by covalent bond with a spacer therebetween, in which the spacer is selected in accordance with the decomposition rate of the covalent bond to the group derived from the physiologically active substance.
- -
-
-
- Properties and synthesis of 2-{2-fluoro (or bromo)-4-[(2-oxocyclopentyl) methyl]phenyl}propanoic acid: Nonsteroidal anti-inflammatory drugs with low membrane permeabilizing and gastric lesion-producing activities
-
We previously proposed that membrane permeabilization activity of NSAIDs is involved in NSAID-induced gastric lesions. We here synthesized derivatives of loxoprofen that have lower membrane permeabilization activity than other NSAIDs. Compared to loxoprofen, the derivatives 10a and 10b have lower membrane permeabilization activity and their oral administration produced fewer gastric lesions but showed an equivalent anti-inflammatory effect. These results suggest that 10a and 10b are likely to be therapeutically beneficial as safer NSAIDs.
- Yamakawa, Naoki,Suemasu, Shintaro,Matoyama, Masaaki,Kimoto, Ayumi,Takeda, Miho,Tanaka, Ken-Ichiro,Ishihara, Tomoaki,Katsu, Takashi,Okamoto, Yoshinari,Otsuka, Masami,Mizushima, Tohru
-
scheme or table
p. 7879 - 7882
(2011/02/22)
-